New insights into how vosoritide affects growth signaling in hypochondroplasia

A new study published in The Journal of Clinical Endocrinology & Metabolism provides insight into how vosoritide, a C-type natriuretic peptide (CNP) analog, affects growth-related biomarkers in children with hypochondroplasia (HCH), revealing…

Continue Reading